Founded in 1984, Dr. Reddy’s is well-known for its industry-leading portfolio of generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharmaceutical companies in more than 80 countries. It has eight USFDA-inspected manufacturing facilities – six in India and one each in Mexico and the UK. Its facilities are supplemented by formulation facilities that provide a wide range of dosage forms. The facilities adhere to cGMP guidelines & are inspected by international regulatory authorities on a regular basis.
KEY PRODUCTS
Market Place
